Evidence map›Paper›PMID 33104440›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia.

John R Lurain, Julian C Schink

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Diagnosis and management of gestational trophoblastic disease: 2025 update.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Review
  4. Review
  5. Diagnosis and management of gestational trophoblastic disease: 2021 update.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021
    Article
  6. Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

John R LurainJohn R. Lurain, MD, Brewer Trophoblastic Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL; and Julian C. Schink, MD, Cancer Treatment Centers of America, Zion, IL.
Julian C SchinkJohn R. Lurain, MD, Brewer Trophoblastic Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL; and Julian C. Schink, MD, Cancer Treatment Centers of America, Zion, IL.
Cancer Treatment Centers of America · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gestational Trophoblastic DiseaseMethotrexateAntibodies, Monoclonal, HumanizedFemaleHumansImmunotherapyPregnancyAntibodies, Monoclonal, HumanizedavelumabMethotrexate

Identifiers

PMID33104440
OpenAlexW3093932148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.